Spectrum Pharmaceuticals Total Assets 2006-2020 | SPPI

Spectrum Pharmaceuticals total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Spectrum Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $263
2018 $391
2017 $487
2016 $429
2015 $419
2014 $490
2013 $499
2012 $505
2011 $281
2010 $164
2009 $173
2008 $130
2007 $58
2006 $53
2005 $65
Spectrum Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2020-03-31 $216
2019-12-31 $263
2019-09-30 $294
2019-06-30 $323
2019-03-31 $353
2018-12-31 $391
2018-09-30 $413
2018-06-30 $465
2018-03-31 $444
2017-12-31 $487
2017-09-30 $502
2017-06-30 $395
2017-03-31 $404
2016-12-31 $429
2016-09-30 $449
2016-06-30 $429
2016-03-31 $401
2015-12-31 $419
2015-09-30 $448
2015-06-30 $454
2015-03-31 $469
2014-12-31 $490
2014-09-30 $510
2014-06-30 $475
2014-03-31 $475
2013-12-31 $499
2013-09-30 $454
2013-06-30 $457
2013-03-31 $482
2012-12-31 $505
2012-09-30 $510
2012-06-30 $388
2012-03-31 $334
2011-12-31 $281
2011-09-30 $266
2011-06-30 $223
2011-03-31 $186
2010-12-31 $164
2010-09-30 $140
2010-06-30 $142
2010-03-31 $143
2009-12-31 $173
2009-09-30 $188
2009-06-30 $148
2009-03-31 $111
2008-12-31 $130
2008-09-30 $55
2008-06-30 $63
2008-03-31 $51
2007-12-31 $58
2007-09-30 $69
2007-06-30 $73
2007-03-31 $47
2006-12-31 $53
2006-09-30 $53
2006-06-30 $57
2006-03-31 $61
2005-12-31 $65
2005-09-30 $70
2005-06-30 $35
2005-03-31 $39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.448B $0.109B
Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.459B 42.94
Takeda Pharmaceutical (TAK) Japan $57.222B 9.97
Astellas Pharma (ALPMY) Japan $29.044B 14.72
Eisai (ESALY) Japan $25.804B 21.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Merck (MKGAF) Germany $17.189B 22.54
Catalent (CTLT) United States $13.657B 52.80
Grifols, S.A (GRFS) Spain $12.541B 15.33
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.735B 41.56
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.852B 49.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.531B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.992B 11.57
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $5.009B 11.58
Arrowhead Pharmaceuticals (ARWR) United States $4.115B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
Hypermarcas (HYPMY) Brazil $3.957B 14.56
FibroGen (FGEN) United States $3.938B 0.00
Nektar Therapeutics (NKTR) United States $3.889B 0.00
ChemoCentryx (CCXI) United States $3.417B 0.00
PTC Therapeutics (PTCT) United States $3.238B 0.00
Sage Therapeutics (SAGE) United States $2.632B 0.00
Pacira BioSciences (PCRX) United States $2.458B 65.56
Taro Pharmaceutical Industries (TARO) Israel $2.404B 11.64
Cronos Group (CRON) Canada $1.973B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.849B 0.00
Xencor (XNCR) United States $1.840B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.34
Ironwood Pharmaceuticals (IRWD) United States $1.626B 11.33
Corcept Therapeutics (CORT) United States $1.611B 14.83
Revolution Medicines (RVMD) United States $1.547B 0.00
Indivior (INVVY) United States $1.545B 19.18
Akebia Therapeutics (AKBA) United States $1.430B 0.00
Heron Therapeutics (HRTX) United States $1.391B 0.00
Zogenix (ZGNX) United States $1.343B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.320B 12.60
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.133B 0.00
Karyopharm Therapeutics (KPTI) United States $1.119B 0.00
Esperion Therapeutics (ESPR) United States $1.049B 0.00
VAXART, INC (VXRT) United States $1.003B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.943B 589.50
Tilray (TLRY) Canada $0.931B 0.00
Translate Bio (TBIO) United States $0.927B 0.00
Altimmune (ALT) United States $0.876B 0.00
Endo (ENDP) Ireland $0.779B 1.15
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.708B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.700B 0.00
Trillium Therapeutics (TRIL) Canada $0.699B 0.00
Collegium Pharmaceutical (COLL) United States $0.633B 0.00
Siga Technologies (SIGA) United States $0.622B 64.00
Flexion Therapeutics (FLXN) United States $0.608B 0.00
Aerie Pharmaceuticals (AERI) United States $0.586B 0.00
Radius Health (RDUS) United States $0.557B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Molecular Templates (MTEM) United States $0.527B 0.00
Ardelyx (ARDX) United States $0.514B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Corbus Pharmaceuticals Holdings (CRBP) United States $0.479B 0.00
DURECT (DRRX) United States $0.467B 0.00
TherapeuticsMD (TXMD) United States $0.454B 0.00
Ocular Therapeutix (OCUL) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.436B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 10.13
Calithera Biosciences (CALA) United States $0.318B 0.00
Harpoon Therapeutics (HARP) United States $0.316B 0.00
IMV INC (IMV) Canada $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.313B 0.00
Redhill Biopharma (RDHL) Israel $0.309B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
MEI Pharma (MEIP) United States $0.295B 0.00
PROFOUND MEDICL (PROF) Canada $0.294B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Lannett Co Inc (LCI) United States $0.251B 5.51
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Aquestive Therapeutics (AQST) United States $0.211B 0.00
Nature's Sunshine Products (NATR) United States $0.209B 20.65
KalVista Pharmaceuticals (KALV) United States $0.207B 0.00
Nivalis Therapeutics (ALPN) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.74
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.137B 0.00
Xeris Pharmaceuticals (XERS) United States $0.126B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
Addex Therapeutics (ADXN) Switzerland $0.115B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
MediWound (MDWD) Israel $0.106B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
Biomerica (BMRA) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
Hemispherx BioPharma (AIM) United States $0.098B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Lipocine (LPCN) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.087B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
PolarityTE (PTE) United States $0.058B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 8.26
GTx (ONCT) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 34.77
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00